Cargando…

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

BACKGROUND: Data on the safety and efficacy of SARS-CoV-2 vaccines in immunocompromised populations are sparse. METHODS: We conducted a prospective study of 77 heart transplant (HT) recipients vaccinated with two doses of BNT162b2 vaccine and monitored for adverse events following both doses, the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Peled, Yael, Ram, Eilon, Lavee, Jacob, Sternik, Leonid, Segev, Amit, Wieder-Finesod, Anat, Mandelboim, Michal, Indenbaum, Victoria, Levy, Itzchak, Raanani, Ehud, Lustig, Yaniv, Rahav, Galia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058049/
https://www.ncbi.nlm.nih.gov/pubmed/34034958
http://dx.doi.org/10.1016/j.healun.2021.04.003